Vaishali Pharma Limited

NSE:VAISHALI.NS

192.25 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 180.798323.96278.954125.656134.227268.098199.979131.59196.644215.575221.792198.61481.385177.277212.672100.29934.563200.298101.747103.85181.975277.256277.25698.19998.199224.35224.35114.47114.47
Kosten van de omzet 151.978330.862246.1782.50299.229238.262151.24291.84765.425231.622176.215164.34562.823177.247176.5477.35330.376175.81282.06780.96172.052262.152262.15281.32281.322201.511201.51198.16898.168
Brutowinst 28.82-6.90232.78443.15434.99829.83648.73739.74431.219-16.04745.57734.26918.5620.0336.13222.9464.18724.48619.6822.899.92315.10415.10416.87716.87722.8422.8416.30316.303
Brutowinstmarge 0.159-0.0210.1180.3430.2610.1110.2440.3020.323-0.0740.2050.1730.22800.170.2290.1210.1220.1930.220.0550.0540.0540.1720.1720.1020.1020.1420.142
Onderzoek- en ontwikkelingskosten 00000000000000000000000000000
Algemene en administratieve kosten 000005.9950006.80600023.34900041.6160004.9784.978006.7276.72700
Verkoop- en marketingkosten 000005.2920000.860000.6630002.10001.0061.006002.1792.17900
Verkoop-, algemene en administratieve kosten 6.57262.314.49810.7025.39311.2878.7648.3569.3427.66616.7686.2362.98624.0124.5294.494.56143.7163.0576.6253.3615.9845.9847.227.228.9078.9075.0035.003
Overige kosten 4.24504.6972.9783.6075.2965.2947.3544.343-16.234.0743.6495.667-10.8343.1113.735.417008.499000000000
Bedrijfskosten 6.57262.314.49817.82213.1123.55214.37815.23710.118-27.99122.73613.1276.884-3.610.21611.1315.14-0.79910.58717.4824.06811.57311.5737.6917.69118.2718.277.527.52
Bedrijfsresultaat 22.248-69.21228.28628.3121.88811.5839.65331.86125.44413.12226.91524.79117.3559.36329.02715.5454.47438.969.09313.9065.775.065.06448.8548.8543.8423.842
Bedrijfsresultaat ratio 0.123-0.2140.1010.2250.1630.0430.1980.2420.2630.0610.1210.1250.2130.0530.1360.1550.1290.1950.0890.1340.0320.0180.0180.0410.0410.0390.0390.0340.034
Totaal overige inkomsten en kosten netto 0.4545.0480.349-4.711-0.697-5.359-4.159-5.273-5.294-6.781-5.484-6.105-6.53-29.031-5.863-5.13-4.441-49.65-5.717-6.087-5.69-1.54-1.54-1.858-1.858-3.649-3.649-2.319-2.319
Inkomen voor belasting 22.702-64.16428.63523.59921.1916.22135.49426.58820.156.34121.43118.68610.825-19.66823.16410.4150.033-10.693.3767.8190.083.523.522.1432.1435.2045.2041.5231.523
Inkomen voor belasting ratio 0.126-0.1980.1030.1880.1580.0230.1770.2020.2080.0290.0970.0940.133-0.1110.1090.1040.001-0.0530.0330.07500.0130.0130.0220.0220.0230.0230.0130.013
Belastingkosten 5.712-17.3397.5166.5635.3321.8668.8746.6475.0374.3125.3594.6712.706-5.1826.0492.7080.01-2.5220.9322.0330.0211.5051.5050.5890.5892.2992.2990.4410.441
Nettowinst 16.99-46.82521.11917.03615.8594.36126.6219.94115.1132.02816.07214.0158.119-14.48517.2157.7070.033-8.1682.4445.7860.0592.0142.0141.5541.5542.9052.9051.0831.083
Nettowinstmarge 0.094-0.1450.0760.1360.1180.0160.1330.1520.1560.0090.0720.0710.1-0.0820.0810.0770.001-0.0410.0240.05600.0070.0070.0160.0160.0130.0130.0090.009
WPA (Winst Per Aandeel) 1.4-4.371.991.611.50.412.521.891.430.191.521.330.77-1.371.630.730.01-0.760.230.550.010.190.190.150.150.270.270.140.14
Verwaterde WPA 1.38-4.371.891.521.410.062.521.891.430.191.521.330.77-1.371.630.730.01-0.760.230.550.010.190.190.150.150.270.270.140.14
EBITDA 23.44-67.80729.52829.54626.69313.10140.84833.30626.32714.62127.94125.8118.37410.49230.08716.5995.5142.2549.69314.8936.4345.7245.6814.6224.6229.4759.524.5084.508
EBITDA ratio 0.13-0.2090.1060.2350.1990.0490.2040.2530.2720.0680.1260.130.2260.0590.1410.1650.1590.2110.0950.1430.0350.0210.020.0470.0470.0420.0420.0390.039